NI
ARGS

Numeric Investors’s Argos Therapeutics, Inc. ARGS Stock Holding History

Numeric Investors’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,827
Closed -$365K – 1165
2014
Q4 		$365K Sell
1,827
-15
-0.8% -$2.7K ﹤0.01% 676
2014
Q3 		$371K Buy
+1,842
New +$288K 0.01% 660

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Numeric Investors's ARGS Position: Q1 2015 in Review

Numeric Investors sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2015, closing a stake of 1,827 shares — an estimated $365K sold.

Numeric Investors first reported a position in ARGS in Q3 2014 and held it in 2 quarters. The position peaked at $371K in Q3 2014. 25 funds tracked by Wall St. Rank hold ARGS as of Q1 2015.

  • Numeric Investors reported no remaining Argos Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Numeric Investors sold 1,827 Argos Therapeutics, Inc. shares in Q1 2015, an estimated $365K.
  • Numeric Investors first reported a position in Argos Therapeutics, Inc. in Q3 2014 and held it in 2 quarters.
  • Numeric Investors's Argos Therapeutics, Inc. position peaked at $371K in Q3 2014.
  • 25 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2015.

Based on Numeric Investors's 13F filing for Q1 2015, filed 8 May 2015.